OrbiMed Makes Big Bet on Xtant Medical Venture capital firm OrbiMed Advisors disclosed a 9.9%, or 1,952,670 shares, stake in Xtant Medical Holdings Inc …
Catalyst Biosciences Inc (NASDAQ:CBIO) investors came back from the hills after the drug maker announced that it has achieved a key milestone under its …
Shares of Catalyst Biosciences Inc (NASDAQ:CBIO) tumbled nearly 21% this morning after investors learned that the hematology company has priced an underwritten public offering …
